Starmer's US pharma deal criticized as costly threat to NHS and public health
By
Aditya Chakrabortty
Summary
Guardian columnist Aditya Chakrabortty argues that Keir Starmer's government has pushed through a law facilitating a US medicine import deal that will cost the NHS billions, diverting funds from doctors, nurses, and cancer care. The piece frames this as a profound democratic failure, asserting that the government is acting against the public interest by prioritizing a trade deal with the US pharmaceutical industry over the health of British citizens, potentially causing harm greater than Covid.
Source
bskyStarmer's US pharma deal criticized as costly threat to NHS and public healththeguardian.comKey quotes
· 3 pulledWe elect politicians to serve our interests. They direct the vital services that look after our families and communities, such as our healthcare and our schools. The entire political system rests on one basic premise: they work for us.
Rather than working for us, Keir Starmer and his ministers are acting against us.
They have rammed through parliament a sweeping law that will, independent experts agree, harm the public.
You might also wanna read
Activists oppose NHS England's use of Palantir software for health records
The article is a strongly opinionated piece opposing NHS England's decision to roll out Palantir's software for managing health records. It
notopalantir.goodlawproject.org·16d agoActivists oppose NHS England's use of Palantir software for health records
The article is a strongly opinionated piece opposing NHS England's decision to roll out Palantir's software for managing health records. It
notopalantir.goodlawproject.org·16d agoThreat in Your Medicine Cabinet: The FDA's Gamble on America's Drugs
U.S. restrictions on Chinese biotech could harm patients, argues editorial
The article argues against U.S. efforts to restrict collaboration with China's biotechnology industry, framing it as an extension of the tec
economist.com·11d ago
Critics question consent, clinical utility, and industry influence in UK's Our Future Health programme
The BMJ investigates concerns about the UK's Our Future Health (OFH) programme, the country's largest ever health research initiative with 1
bmj.com·7d ago
UK MP Zarah Sultana Calls for Banning Palantir from Public Service Contracts Over Human Rights Concerns
UK MP Zarah Sultana argues that Palantir, a data analytics company founded to maintain US global domination, should be excluded from UK publ
opendemocracy.net·5mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.